These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37106785)

  • 1. The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases.
    Rades D; Johannwerner L; Werner EM; Cremers F; Yu NY
    Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
    Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
    Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Dziggel L; Gebauer N; Bartscht T; Schild SE; Rades D
    Anticancer Res; 2018 Apr; 38(4):2391-2394. PubMed ID: 29599366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-cerebral Metastasis - An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT).
    Rades D; Nguyen T; Schild SE
    Anticancer Res; 2020 May; 40(5):2841-2845. PubMed ID: 32366432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.
    Rades D; Sehmisch L; Hansen HC; Dziggel L; Janssen S; Schild SE
    Anticancer Res; 2019 Mar; 39(3):1501-1505. PubMed ID: 30842188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost.
    Du TQ; Li X; Zhong WS; Tian JD; Zhao YX; Liu D
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):569-577. PubMed ID: 32851477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer.
    Nguyen T; Bartscht T; Schild SE; Rades D
    Anticancer Res; 2020 Mar; 40(3):1665-1668. PubMed ID: 32132072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases.
    Rades D; Janssen S; Bajrovic A; Khoa MT; Veninga T; Schild SE
    Radiat Oncol; 2017 Apr; 12(1):69. PubMed ID: 28438175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.
    Bauman G; Yartsev S; Roberge D; MacRae R; Roa W; Panet-Raymond V; Masucci L; Yaremko B; D'Souza D; Palma D; Sexton T; Yu E; Pantarotto JR; Ahmad B; Fisher B; Dar AR; Lambert C; Pond G; Stitt L; Tay KY; Rodrigues G
    J Neurooncol; 2016 Jul; 128(3):431-6. PubMed ID: 27084705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
    Rades D; Hansen HC; Schild SE; Janssen S
    Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
    Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
    Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
    Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
    Rades D; Fischer D; Veninga T; Stalpers LJ; Schild SE
    Gynecol Oncol; 2009 Sep; 114(3):506-8. PubMed ID: 19540574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.